338 filings
Page 12 of 17
8-K
dun5u5vyhyxpjh
21 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
dd4ud77zst0
28 Oct 15
Other Events
12:00am
8-K
5q0xynu1 s1u8s97sh
19 Oct 15
Other Events
12:00am
8-K
pt5ve
15 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
z0hof rw3m6q7niq
30 Sep 15
Sorrento Therapeutics and City of Hope Announce Exclusive License to Develop First-in-class Immunotherapies Against Intracellular Targets
12:00am
8-K
emfxcsp
9 Sep 15
Sorrento to Present at Upcoming Conferences
12:00am
8-K
bhdthc nigy
17 Aug 15
Other Events
12:00am
8-K
dlcbca3v2v3 dzeu
11 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
n1p2r2pflka 9t3cl
10 Aug 15
Sorrento’s TNK Therapeutics Subsidiary Acquires
12:00am
8-K
ryn7d wrfld9ydyqs42
3 Aug 15
Other Events
12:00am
8-K
m1a1xm0 tf75v8utwfa0
20 Jul 15
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
12:00am
8-K
4zs5s29 0zcz91v
9 Jul 15
Sorrento and NantBioScience Form Joint Venture to Develop Moonshot Program Targeted Small Molecule Therapies against Cancer
12:00am
8-K
9ju54rr95kxro0232s
29 Jun 15
Other Events
12:00am
8-K
0hkr6f7z
29 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
46mmn71m
24 Jun 15
ARK Animal Health, a Subsidiary of Sorrento Therapeutics, Announces Receipt
12:00am
8-K
jr7o7fe
5 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5nq 07copjz7tmhq0
3 Jun 15
Other Events
12:00am
8-K
591z8
26 May 15
Sorrento to Present at the 2015 Jefferies Healthcare Conference and at Other Conferences
12:00am
8-K
tsrszat sfaor1
18 May 15
Other Events
12:00am
8-K
qku xvlnpn
15 May 15
Nantworks Acquires Cynviloq™ for Up to $1.3+ Billion
12:00am